-
1Conference
المؤلفون: Rathmayer, M., Heinlein, W., Offermanns, M., Heber, R., Lynen, P., Albert, J.
المصدر: Viszeralmedizin 2023 77. Jahrestagung der DGVS mit Sektion Endoskopie Herbsttagung der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie mit den Arbeitsgemeinschaften der DGAV und Jahrestagung der CACP ; Zeitschrift für Gastroenterologie ; ISSN 1439-7803
-
2Conference
المؤلفون: Rathmayer, M., Heinlein, W., Albert, J.
المصدر: Viszeralmedizin 2023 77. Jahrestagung der DGVS mit Sektion Endoskopie Herbsttagung der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie mit den Arbeitsgemeinschaften der DGAV und Jahrestagung der CACP ; Zeitschrift für Gastroenterologie ; ISSN 1439-7803
-
3Academic Journal
المؤلفون: Wilke, M, Heinlein, W, Stiefenhofer, L, Bodmann, KF
المصدر: GMS Infectious Diseases; VOL: 8; DOC25 /20201215/
مصطلحات موضوعية: rapid bacteria identification, antimicrobial susceptibility testing, AST, sepsis, bloodstream infections, antimicrobial stewardship, health economics, costs, ddc: 610
Relation: Abraham K, Dolman HS, Zimmerman LH, Faris J, Edelman DA, Baylor A, Wilson RF, Tyburski JG. Impact of inappropriate initial antibiotics in critically ill surgical patients with bacteremia. Am J Surg. 2016 Mar;211(3):593-8. DOI:10.1016/j.amjsurg.2015.10.025; Battle SE, Bookstaver PB, Justo JA, Kohn J, Albrecht H, Al-Hasan MN. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017 Jan;72(1):299-304. DOI:10.1093/jac/dkw402; Bauer KA, Perez KK, Forrest GN, Goff DA. Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis. 2014 Oct;59 Suppl 3:S134-45. DOI:10.1093/cid/ciu547; Bilir SP, Ferrufino CP, Pfaller MA, Munakata J. The economic impact of rapid Candida species identification by T2Candida among high-risk patients. Future Microbiol. 2015;10(7):1133-44. DOI:10.2217/fmb.15.29; Charnot-Katsikas A, Tesic V, Love N, Hill B, Bethel C, Boonlayangoor S, Beavis KG. Use of the Accelerate Pheno System for Identification and Antimicrobial Susceptibility Testing of Pathogens in Positive Blood Cultures and Impact on Time to Results and Workflow. J Clin Microbiol. 2018 Jan;56(1):e01166-17. DOI:10.1128/JCM.01166-17; Dargère S, Cormier H, Verdon R. Contaminants in blood cultures: importance, implications, interpretation and prevention. Clin Microbiol Infect. 2018 Sep;24(9):964-9. DOI:10.1016/j.cmi.2018.03.030; Davey P, Marwick CA, Scott CL, Charani E, McNeil K, Brown E, Gould IM, Ramsay CR, Michie S. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017 Feb;2:CD003543. DOI:10.1002/14651858.CD003543.pub4; De Waele JJ, Akova M, Antonelli M, Canton R, Carlet J, De Backer D, Dimopoulos G, Garnacho-Montero J, Kesecioglu J, Lipman J, Mer M, Paiva JA, Poljak M, Roberts JA, Rodriguez Bano J, Timsit JF, Zahar JR, Bassetti M. Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance. Intensive Care Med. 2018 Feb;44(2):189-96. DOI:10.1007/s00134-017-5036-1; Descours G, Desmurs L, Hoang TLT, Ibranosyan M, Baume M, Ranc AG, Fuhrmann C, Dauwalder O, Salka W, Vandenesch F. Evaluation of the Accelerate Pheno(TM) system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections. Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1573-83. DOI:10.1007/s10096-018-3287-6; Dubourg G, Lamy B, Ruimy R. Rapid phenotypic methods to improve the diagnosis of bacterial bloodstream infections: meeting the challenge to reduce the time to result. Clin Microbiol Infect. 2018 Sep;24(9):935-43. DOI:10.1016/j.cmi.2018.03.031; Galar A, Leiva J, Espinosa M, Guillén-Grima F, Hernáez S, Yuste JR. Clinical and economic evaluation of the impact of rapid microbiological diagnostic testing. J Infect. 2012 Oct;65(4):302-9. DOI:10.1016/j.jinf.2012.06.006; Kalich BA, Maguire JM, Campbell-Bright SL, Mehrotra A, Caffey T, Tulu Z, Lin FC, Carson SS. Impact of an Antibiotic-specific Sepsis Bundle on Appropriate and Timely Antibiotic Administration for Severe Sepsis in the Emergency Department. J Emerg Med. 2016 Jan;50(1):79-88.e1. DOI:10.1016/j.jemermed.2015.09.007; Kerremans JJ, Verboom P, Stijnen T, Hakkaart-van Roijen L, Goessens W, Verbrugh HA, Vos MC. Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother. 2008 Feb;61(2):428-35. DOI:10.1093/jac/dkm497; Kidd SP. Evaluation of the Accelerate Pheno(TM) System versus current blood culture ID/AST: methods and potential impact on antimicrobial stewardship and patient management [Poster]. In: 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); 2018 Apr 21-24; Madrid, Spain.; Lockwood AM, Perez KK, Musick WL, Ikwuagwu JO, Attia E, Fasoranti OO, Cernoch PL, Olsen RJ, Musser JM. Integrating Rapid Diagnostics and Antimicrobial Stewardship in Two Community Hospitals Improved Process Measures and Antibiotic Adjustment Time. Infect Control Hosp Epidemiol. 2016 Apr;37(4):425-32. DOI:10.1017/ice.2015.313; Marquet K, Liesenborgs A, Bergs J, Vleugels A, Claes N. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Crit Care. 2015 Feb;19:63. DOI:10.1186/s13054-015-0795-y; Marschal M, Bachmaier J, Autenrieth I, Oberhettinger P, Willmann M, Peter S. Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens. J Clin Microbiol. 2017 Jul;55(7):2116-26. DOI:10.1128/JCM.00181-17; Martin J, Bauer M, Bauer K, Schleppers A. Calculation of DRG revenue, actual costs and profit margin of anaesthesiological services. Anästh Intensivmed. 2008;49:223-32.; Menéndez R, Torres A, Reyes S, Zalacain R, Capelastegui A, Aspa J, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, de Castro FR, Rello J, Molinos L, Ruiz-Manzano J. Initial management of pneumonia and sepsis: factors associated with improved outcome. Eur Respir J. 2012 Jan;39(1):156-62. DOI:10.1183/09031936.00188710; Micek ST, Welch EC, Khan J, Pervez M, Doherty JA, Reichley RM, Kollef MH. Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother. 2010 May;54(5):1742-8. DOI:10.1128/AAC.01365-09; Mushtaq A, Awali RA, Chandramohan S, Krishna A, Biedron C, Jegede O, Chopra T. Implementing an antibiotic stewardship program at a long-term acute care hospital in Detroit, Michigan. Am J Infect Control. 2017 Dec;45(12):e157-e160. DOI:10.1016/j.ajic.2017.07.028; Pancholi P, Carroll KC, Buchan BW, Chan RC, Dhiman N, Ford B, Granato PA, Harrington AT, Hernandez DR, Humphries RM, Jindra MR, Ledeboer NA, Miller SA, Mochon AB, Morgan MA, Patel R, Schreckenberger PC, Stamper PD, Simner PJ, Tucci NE, Zimmerman C, Wolk DM. Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis. J Clin Microbiol. 2018 Apr;56(4):e01329-17. DOI:10.1128/JCM.01329-17; Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010 Nov;54(11):4851-63. DOI:10.1128/AAC.00627-10; Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, Musser JM. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect. 2014 Sep;69(3):216-25. DOI:10.1016/j.jinf.2014.05.005; Périllaud C, Pilmis B, Diep J, Péan de Ponfilly G, Vidal B, Couzigou C, Mizrahi A, Lourtet-Hascoët J, Le Monnier A, Nguyen Van JC. Prospective evaluation of rapid antimicrobial susceptibility testing by disk diffusion on Mueller-Hinton rapid-SIR directly on blood cultures. Diagn Microbiol Infect Dis. 2019 Jan;93(1):14-21. DOI:10.1016/j.diagmicrobio.2018.07.016; Sango A, McCarter YS, Johnson D, Ferreira J, Guzman N, Jankowski CA. Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species. J Clin Microbiol. 2013 Dec;51(12):4008-11. DOI:10.1128/JCM.01951-13; Savage RD, Fowler RA, Rishu AH, Bagshaw SM, Cook D, Dodek P, Hall R, Kumar A, Lamontagne F, Lauzier F, Marshall J, Martin CM, McIntyre L, Muscedere J, Reynolds S, Stelfox HT, Daneman N. The Effect of Inadequate Initial Empiric Antimicrobial Treatment on Mortality in Critically Ill Patients with Bloodstream Infections: A Multi-Centre Retrospective Cohort Study. PLoS One. 2016;11(5):e0154944. DOI:10.1371/journal.pone.0154944; Shorr AF, Micek ST, Welch EC, Doherty JA, Reichley RM, Kollef MH. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med. 2011 Jan;39(1):46-51. DOI:10.1097/CCM.0b013e3181fa41a7; Sofjan AK, Casey BO, Xu BA, Amadio J, Restrepo A, Alam MJ, Garey KW. Accelerate PhenoTest BC Kit Versus Conventional Methods for Identification and Antimicrobial Susceptibility Testing of Gram-Positive Bloodstream Isolates: Potential Implications for Antimicrobial Stewardship. Ann Pharmacother. 2018 Aug;52(8):754-62. DOI:10.1177/1060028018765486; Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, Roberts JA, Schouten J, Giamarellou H, Rello J, De Waele J, Shorr AF, Leone M, Poulakou G, Depuydt P, Garnacho-Montero J. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med. 2020 Feb;46(2):245-65. DOI:10.1007/s00134-019-05866-w; Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, Tacey M, Timsit JF, Leone M, Zahar JR, De Waele JJ. A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit. Clin Infect Dis. 2016 Apr;62(8):1009-17. DOI:10.1093/cid/civ1199; Timbrook TT, Morton JB, McConeghy KW, Caffrey AR, Mylonakis E, LaPlante KL. The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis. Clin Infect Dis. 2017 Jan;64(1):15-23. DOI:10.1093/cid/ciw649; Tumbarello M, Spanu T, Di Bidino R, Marchetti M, Ruggeri M, Trecarichi EM, De Pascale G, Proli EM, Cauda R, Cicchetti A, Fadda G. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother. 2010 Oct;54(10):4085-91. DOI:10.1128/AAC.00143-10; Van Hal SJ, Frostis V, Miyakis S, Marriott D, Harkness J. Prevalence and significance of coagulase-negative staphylococci isolated from blood cultures in a tertiary hospital. Scand J Infect Dis. 2008;40(6-7):551-4. DOI:10.1080/00365540701877304; Ward E, Weller K, Gomez J, Roman K, Cárdenas AM. Evaluation of a Rapid System for Antimicrobial Identification and Antimicrobial Susceptibility Testing in Pediatric Bloodstream Infections. J Clin Microbiol. 2018 Sep;56(9):e00762-18. DOI:10.1128/JCM.00762-18; Wawrzeniak IC, Loss SH, Moraes MC, De La Vega FL, Victorino JA. Could a protocol based on early goal-directed therapy improve outcomes in patients with severe sepsis and septic shock in the Intensive Care Unit setting? Indian J Crit Care Med. 2015 Mar;19(3):159-65. DOI:10.4103/0972-5229.152759; Welker A, Schleppers A, Saathoff H, Mende H. DRG-based contribution margin accounting: A useful instrument for the evaluation of reorganization measures in anaesthesiology? An orienting monocentric study. Anästh Intensivmed. 2011;52:S534-7.; Zapp W, editor. Deckungsbeitragsrechnung für Krankenhäuser: Analyse - Verfahren - Praxisbeispiele. Controlling im Krankenhaus. Wiesbaden, Germany: Springer Gabler; 2019. DOI:10.1007/978-3-658-25414-8; http://dx.doi.org/10.3205/id000069; http://nbn-resolving.de/urn:nbn:de:0183-id0000691; http://www.egms.de/en/journals/id/2020-8/id000069.shtml
-
4Conference
المؤلفون: Wilke, MH, Worf, K, Heinlein, W, Bodmann, KF
المصدر: Infektiologie Update 2018; 26. Jahrestagung der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG); 20181004-20181006; Wien; DOC18peg24 /20181008/
مصطلحات موضوعية: ddc: 610
Relation: American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416.; Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(21):2063.; Arefian H, Heublein S, Scherag A, Brunkhorst FM, Younis MZ, Moerer O, Fischer D, Hartmann M. Hospital-related cost of sepsis: A systematic review. J Infect. 2017 Feb;74(2):107-117.; Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011 Mar-Apr;10(2):150-61.; Chastre J, Blasi F, Masterton RG, Rello J, Torres A, Welte T. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clin Microbiol Infect. 2014;20 Suppl 4:19-36.; Çakir Edis E, Hatipoglu ON, Yilmam I, Süt N. Economic burden of nosocomial pneumonia in non-intensive care clinics. Tuberk Toraks. 2015;63(1):8-12.; Dick A, Liu H, Zwanziger J, Perencevich E, Furuya EY, Larson E, Pogorzelska-Maziarz M, Stone PW. Long-term survival and healthcare utilization outcomes attributable to sepsis and pneumonia. BMC Health Serv Res. 2012;12:432.; Dietrich ES, Demmler M, Schulgen G, Fekec K, Mast O, Pelz K, Daschner FD. Nosocomial pneumonia: a cost-of-illness analysis. Infection. 2002 Apr;30(2):61-7.; Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med. 2007 Apr;33(4):606-18.; European Centre for Disease Prevention and Control. Healthcare-associated infections acquired in intensive care units. Annual epidemiological report for 2015. Stockholm: ECDC; 2017.; European Respiratory Society. Stop pneumonia: strengthen strategies to protect, prevent and treat. European Respiratory Society; 2017 [updated 13 November 2017].; Fleischmann C, Thomas-Rueddel DO, Hartmann M, Hartog CS, Welte T, Heublein S, Dennler U, Reinhart K. Hospital Incidence and Mortality Rates of Sepsis. Dtsch Arztebl Int. 2016;113(10):159-66.; González C, Rubio M, Romero-Vivas J, González M, Picazo JJ. Staphylococcus aureus bacteremic pneumonia: differences between community and nosocomial acquisition. Int J Infect Dis. 2003 Jun;7(2):102-8.; Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010;51 Suppl 1:S81-7.; Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O'Grady NP, Bartlett JG, Carratalà J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016 Sep 1;63(5):e61-e111.; Karakoc C, Tekin R, Ysilbag Z, Cagatay A. Risk factors for mertalitiy in patients with nosocomial Gram-negative rod bacteremia. Eur Rev Med Pharmacol Sci. 2013;17(7):951-7.; Kim YJ, Kim SI, Hong K-W, Kim YR, Park YJ, Kang M-W. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy. J Korean Med Sci. 2012;27:471-5.; Liang SY, Kumar A. Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance. Curr Infect Dis Rep. 2015 Jul;17(7):493.; Mamani M, Hashemi S, Hajilooi M, Saedi F, Niayesh A, Fallah M. Evaluation of fibronectin and C-reactive protein levels in patients with sepsis: a case-control study. Acta Med Iran. 2013;50(6):404-10.; Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012;10(6):701-6.; Ott E, Bange FC, Reichardt C, Graf K, Eckstein M, Schwab F, et al. Costs of nosocomial pneumonia caused by meticillin-resistant Staphylococcus aureus. J Hosp Infect. 2010;76(4):300-3.; Retamar P, López-Prieto MD, Rodríguez-López F, de Cueto M, García MV, González-Galan V, Del Arco A, Pérez-Santos MJ, Téllez-Pérez F, Becerril-Carral B, Martín-Aspas A, Arroyo A, Pérez-Cortés S, Acosta F, Florez C, León-Ruiz L, Muñoz-Medina L, Rodríguez-Baño J; SAEI/SAMPAC/REIPI Bacteremia Group. Predictors of early mortality in very elderly patients with bacteremia: a prospective multicenter cohort. Int J Infect Dis. 2014 Sep;26:83-7. DOI:10.1016/j.ijid.2014.04.029; Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017 Mar;43(3):304-377.; Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55.; Rosenthal VD, Guzman S, Migone O, Safdar N. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis. Am J Infect Control. 2005;33(3):157-61.; Russell CD, Koch O, Laurenson IF, O'Shea DT, Sutherland R, Mackintosh CL. Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study. J Hosp Infect. 2016;92(3):273-9.; Sampedro GR, Bubeck Wardenburg J. Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach? J Infect Dis. 2017 Feb 15;215(suppl_1):S64-S70.; Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama. 2016;315(8):801-10.; Sopena N, Sabria M. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest. 2005;127(1):213-9.; Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57(12):1288-94.; Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, Timsit JF, Welte T, Wunderink R. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017 Sep 10;50(3). pii: 1700582. DOI:10.1183/13993003.00582-2017; Torres A, Ewig S, Lode H, Carlet J. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med. 2009;35(1):9-29.; Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D; Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006 Feb;34(2):344-53.; Volakli E, Spies C, Michalopoulos A, Groeneveld AB, Sakr Y, Vincent JL. Infections of respiratory or abdominal origin in ICU patients: what are the differences? Crit Care. 2010;14(2):R32.; http://dx.doi.org/10.3205/18peg24; http://nbn-resolving.de/urn:nbn:de:0183-18peg248; http://www.egms.de/en/meetings/peg2018/18peg24.shtml
-
5Conference
المؤلفون: Bodmann, KF, Worf, K, Preisendörfer, B, Heinlein, W, Kast, T, Wilke, MH
المصدر: Infektiologie Update 2018; 26. Jahrestagung der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG); 20181004-20181006; Wien; DOC18peg25 /20181008/
مصطلحات موضوعية: ddc: 610
Relation: Al-Omari A, Cameron DW, Lee C, Corrales-Medina VF. Oral antibiotic therapy for the treatment of infective endocarditis: A systematic review. BMC Infect Dis. 2014;14:140. DOI:10.1186/1471-2334-14-140; Arena F, Romanini E, Rosi E, Salomone C, Tucci G, Pempinello C, Fantoni M. The role of dalbavancin in the multi-disciplinary management of wound infections in orthopaedic surgery. J Chemother. 2018;30(3):131-9. DOI:10.1080/1120009X.2017.1404277; Bartkowski R. Spital-Verweildauer unter DRG-Bedingungen. Ther Umsch. 2012;69(1):15-21. DOI:10.1024/0040-5930/a000245; Bouza E, Valerio M, Soriano A, Morata L, Carus EG, Rodríguez-González C, Hidalgo-Tenorio MC, Plata A, Muñoz P, Vena A; DALBUSE Study Group (Dalbavancina: Estudio de su uso clinico en España). Dalbavancin in the treatment of different gram-positive infections: a real-life experience. Int J Antimicrob Agents. 2018;51(4):571-7. DOI:10.1016/j.ijantimicag.2017.11.008; Bowling JE, Lewis JS, Owens AD. Outpatient Parenteral Antimicrobial Therapy. Hosp Med Clin. 2013;2(1):e45-e56. DOI:10.1016/j.ehmc.2012.07.002; Buehrle DJ, Shields RK, Shah N, Shoff C, Sheridan K. Risk Factors Associated With Outpatient Parenteral Antibiotic Therapy Program Failure Among Intravenous Drug Users. Open Forum Infect Dis. 2017;4(3):ofx102. DOI:10.1093/ofid/ofx102; Chapman AL, Seaton RA, Cooper MA, Hedderwick S, Goodall V, Reed C, Sanderson F, Nathwani D; BSAC/BIA OPAT Project Good Practice Recommendations Working Group. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother. 2012;67(5):1053-62. DOI:10.1093/jac/dks003.; Cots F, Chiarello P, Salvador X, Castells X, Quentin W. DRG-based hospital payment: Intended and unintended consequences. In: Busse R, Geissler A, Quentin W, Wiley M, editors. Diagnosis related groups in Europe: moving towards transparency, efficiency and quality in hospitals. Open University Press; 2011. p. 75-92.; Debatin JF, Ekkernkamp A, Schulte B, Baehr M, editors. Krankenhausmanagement: Strategien, Konzepte, Methoden. Berlin: Med. Wiss. Verl.-Ges; 2010.; Dunne MW, Puttagunta S, Sprenger CR, Rubino C, van Wart S, Baldassarre J. Extended-duration dosing and distribution of dalbavancin into bone and articular tissue. Antimicrob Agents Chemother. 2015;59(4):1849-55. DOI:10.1128/AAC.04550-14; Eckmann C, Lawson W, Nathwani D, Solem CT, Stephens JM, Macahilig C, Simoneau D, Hajek P, Charbonneau C, Chambers R, Li JZ, Haider S. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria. Int J Antimicrob Agents. 2014 Jul;44(1):56-64. DOI:10.1016/j.ijantimicag.2014.04.007; Eells SJ, Nguyen M, Jung J, Macias-Gil R, May L, Miller LG. Relationship between Adherence to Oral Antibiotics and Postdischarge Clinical Outcomes among Patients Hospitalized with Staphylococcus aureus Skin Infections. Antimicrob Agents Chemother. 2016;60(5):2941-8. DOI:10.1128/AAC.02626-15; Falagas ME, Karagiannis, Apostolos K A, Nakouti T, Tansarli GS. Compliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials. PloS One. 2015;10(1):e0116207. DOI:10.1371/journal.pone.0116207; Falconer S. Reduced hospital stays for skin infections treated with dalbavancin. In: 28th European Congress of Clinical Microbiology and Infectious Diseases ECCMID; 2018 Apr 21-24; Madrid, Spain. P0282.; Felder S. The variance of length of stay and the optimal DRG outlier payments. Int J Health Care Finance Econ. 2009;9(3):279-89. DOI:10.1007/s10754-008-9051-1; GKV-Spitzenverband; Verband der Privaten Krankenversicherung; Deutsche Krankenhausgesellschaft. Vereinbarung zum Fallpauschalensystem für Krankenhäuser für das Jahr 2018 (Fallpauschalenvereinbarung 2018 - FPV 2018). 2018.; Holland TL, Arnold C, Fowler VG. Clinical management of Staphylococcus aureus bacteremia: A review. JAMA. 2014;312(13):1330-41. DOI:10.1001/jama.2014.9743; Hübner C, Hübner NO, Hopert K, Maletzki S, Flessa S. Analysis of MRSA-attributed costs of hospitalized patients in Germany. Eur J Clin Microbiol Infect Dis. 2014;33(10):1817-22. DOI:10.1007/s10096-014-2131-x; InEK GmbH. Fallpauschalenkatalog 2018.; Itani, Kamal M F, Dryden MS, Bhattacharyya H, Kunkel MJ, Baruch AM, Weigelt JA. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. Am J Surg. 2010;199(6):804-16. DOI:10.1016/j.amjsurg.2009.08.045; Jenkins TC, Sabel AL, Sarcone EE, Price CS, Mehler PS, Burman WJ. Skin and soft-tissue infections requiring hospitalization at an academic medical center: Opportunities for antimicrobial stewardship. Clin Infect Dis. 2010;51(8):895-903. DOI:10.1086/656431; Jerosch J, Linke C, editors. Patientenzentrierte Medizin in Orthopädie und Unfallchirurgie: Lösungen für Patientenorientierung, Qualität und Wirtschaftlichkeit. Berlin, Heidelberg: Springer; 2016.; Juul JJ, Mullins CF, Peppard WJ, Huang AM. New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin. Ther Clin Risk Manag. 2016;12:225-32. DOI:10.2147/TCRM.S71855; Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother. 2002;49(6):897-903. DOI:10.1093/jac/dkf046; Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro Torné A, Witte W, Friedrich AW. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill. 2010;15(41):19688.; Laupland KB, Valiquette L. Outpatient parenteral antimicrobial therapy. Can J Infect Dis Med Microbiol. 2013;24(1):9-11.; Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: What have we learned from 30 years of clinical trials? Int J Infect Dis. 2005;9(3):127-38. DOI:10.1016/j.ijid.2004.09.009; Lener S, Hartmann S, Barbagallo GMV, Certo F, Thomé C, Tschugg A. Management of spinal infection: A review of the literature. Acta Neurochir (Wien). 2018;160(3):487-96. DOI:10.1007/s00701-018-3467-2; Li JZ, Willke RJ, Rittenhouse BE, Rybak MJ. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial. Surg Infect (Larchmt). 2003;4(1):57-70. DOI:10.1089/109629603764655290; Linke C. Verweildauer als Zielparameter der Patientenversorgung aus ökonomischer und medizinischer Sicht. In: Jerosch J, Linke C, editors. Patientenzentrierte Medizin in Orthopädie und Unfallchirurgie. Berlin, Heidelberg: Springer; 2016. DOI:10.1007/978-3-662-48081-6_11; Martí-Carvajal AJ, Dayer M, Conterno LO, Gonzalez Garay AG, Martí-Amarista CE, Simancas-Racines D. A comparison of different antibiotic regimens for the treatment of infective endocarditis. Cochrane Database Syst Rev. 2016;4:CD009880. DOI:10.1002/14651858.CD009880.pub2; Nair T, Fitzgerald J, Ly B, Wallace MR. Dalbavancin as a cost effective antibiotic. Infect Dis (Lond). 2018;50(1):75-6. DOI:10.1080/23744235.2017.1365169.; Nathwani D, Dryden M, Garau J. Early clinical assessment of response to treatment of skin and soft-tissue infections: How can it help clinicians? Perspectives from Europe. Int J Antimicrob Agents. 2016;48(2):127-36. DOI:10.1016/j.ijantimicag.2016.04.023; Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis. 2010;51 Suppl 2:S198-208. DOI:10.1086/653520; Rao N, Ziran BH, Lipsky BA. Treating osteomyelitis: Antibiotics and surgery. Plast Reconstr Surg. 2011;127 Suppl 1:177S-187S. DOI:10.1097/PRS.0b013e3182001f0f; Resch A, Wilke M, Fink C. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals. Eur J Health Econ. 2009;10(3):287-97. DOI:10.1007/s10198-008-0132-3; Rodvold KA, McConeghy KW. Methicillin-resistant Staphylococcus aureus therapy: Past, present, and future. Clin Infect Dis. 2014;58 Suppl 1:S20-7. DOI:10.1093/cid/cit614; Roeder N, Hensen P, Franz D, editors. Gesundheitsökonomie, Gesundheitssystem und öffentliche Gesundheitspflege: Ein praxisorientiertes Kurzlehrbuch. 2 ed. Köln: Dt. Ärzte-Verl.; 2014.; Sharpe JN, Shively EH, Polk HC. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. Am J Surg. 2005;189(4):425-8. DOI:10.1016/j.amjsurg.2005.01.011; Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, Gainer RB, Kunkel MJ, Yancey RW, Williams DN; IDSA. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis. 2004;38(12):1651-72. DOI:10.1086/420939; Tobudic S, Forstner C, Burgmann H, Lagler H, Ramharter M, Steininger C, Vossen MG, Winkler S, Thalhammer F. Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna. Clin Infect Dis. 2018;67(5):795-8. DOI:10.1093/cid/ciy279; Walsh TL, Chan L, Konopka CI, Burkitt MJ, Moffa MA, Bremmer DN, Murillo MA, Watson C, Chan-Tompkins NH. Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients. BMC Infect Dis. 2016 Nov 29;16(1):721. DOI:10.1186/s12879-016-2067-0; http://dx.doi.org/10.3205/18peg25; http://nbn-resolving.de/urn:nbn:de:0183-18peg258; http://www.egms.de/en/meetings/peg2018/18peg25.shtml
-
6Academic Journal
المؤلفون: Wilke, M, Worf, K, Preisendörfer, B, Heinlein, W, Kast, T, Bodmann, KF
المصدر: GMS Infectious Diseases; VOL: 7; DOC03 /20191023/
مصطلحات موضوعية: single-dose intravenous Dalbavancin, health economic model, length of stay, cost savings, ddc: 610
Relation: Al-Omari A, Cameron DW, Lee C, Corrales-Medina VF. Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review. BMC Infect Dis. 2014 Mar;14:140. DOI:10.1186/1471-2334-14-140; Allergan Pharmaceuticals International Ltd. Xydalba (Dalbavancin) EU SmPC_EN_Dec 2018: Summary of Product Characteristics. EU/1/14/986/001. Dublin; 2015.; Anderson DJ, Kaye KS, Chen LF, Schmader KE, Choi Y, Sloane R, Sexton DJ. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS ONE. 2009 Dec;4(12):e8305. DOI:10.1371/journal.pone.0008305; Arena F, Romanini E, Rosi E, Salomone C, Tucci G, Pempinello C, Fantoni M. The role of dalbavancin in the multi-disciplinary management of wound infections in orthopaedic surgery. J Chemother. 2018 May;30(3):131-9. DOI:10.1080/1120009X.2017.1404277; Bartkowski R. Spital-Verweildauer unter DRG-Bedingungen [Length of hospital stay due to DRG reimbursement]. Ther Umsch. 2012 Jan;69(1):15-21. DOI:10.1024/0040-5930/a000245; Bouza E, Valerio M, Soriano A, Morata L, Carus EG, Rodríguez-González C, Hidalgo-Tenorio MC, Plata A, Muñoz P, Vena A; DALBUSE Study Group (Dalbavancina: Estudio de su uso clinico en España). Dalbavancin in the treatment of different gram-positive infections: a real-life experience. Int J Antimicrob Agents. 2018 Apr;51(4):571-7. DOI:10.1016/j.ijantimicag.2017.11.008; Bowling JE, Lewis JS, Owens AD. Outpatient Parenteral Antimicrobial Therapy. Hosp Med Clin. 2013;2(1):e45-56. DOI:10.1016/j.ehmc.2012.07.002; Buehrle DJ, Shields RK, Shah N, Shoff C, Sheridan K. Risk Factors Associated With Outpatient Parenteral Antibiotic Therapy Program Failure Among Intravenous Drug Users. Open Forum Infect Dis. 2017;4(3):ofx102. DOI:10.1093/ofid/ofx102; Chapman AL, Seaton RA, Cooper MA, Hedderwick S, Goodall V, Reed C, Sanderson F, Nathwani D; BSAC/BIA OPAT Project Good Practice Recommendations Working Group. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother. 2012 May;67(5):1053-62. DOI:10.1093/jac/dks003; Cots F, Chiarello P, Salvador X, Quentin W. DRG-based hospital payment: intended and unintended consequences. In: Busse R, Geissler A, Quentin W, Wiley M, editors. Diagnosis related groups in Europe: moving towards transparency, efficiency and quality in hospitals. Open University Press; 2011. p. 75-92.; Debatin JF, Ekkernkamp A, Schulte B, Baehr M, editors. Krankenhausmanagement: Strategien, Konzepte, Methoden. Berlin: Med. Wiss. Verl.-Ges; 2010.; Dunne MW, Talbot GH, Boucher HW, Wilcox M, Puttagunta S. Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies. Drug Saf. 2016 Feb;39(2):147-57. DOI:10.1007/s40264-015-0374-9; Dunne MW, Puttagunta S, Sprenger CR, Rubino C, Van Wart S, Baldassarre J. Extended-duration dosing and distribution of dalbavancin into bone and articular tissue. Antimicrob Agents Chemother. 2015 Apr;59(4):1849-55. DOI:10.1128/AAC.04550-14; Eckmann C, Lawson W, Nathwani D, Solem CT, Stephens JM, Macahilig C, Simoneau D, Hajek P, Charbonneau C, Chambers R, Li JZ, Haider S. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria. Int J Antimicrob Agents. 2014 Jul;44(1):56-64. DOI:10.1016/j.ijantimicag.2014.04.007; Eells SJ, Nguyen M, Jung J, Macias-Gil R, May L, Miller LG. Relationship between Adherence to Oral Antibiotics and Postdischarge Clinical Outcomes among Patients Hospitalized with Staphylococcus aureus Skin Infections. Antimicrob Agents Chemother. 2016 05;60(5):2941-8. DOI:10.1128/AAC.02626-15; El-Masri MM, Hammad TA, McLeskey SW, Joshi M, Korniewicz DM. Predictors of nosocomial bloodstream infections among critically ill adult trauma patients. Infect Control Hosp Epidemiol. 2004 Aug;25(8):656-63. DOI:10.1086/502457; European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2016: Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2017.; Falagas ME, Karagiannis AK, Nakouti T, Tansarli GS. Compliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials. PLoS ONE. 2015;10(1):e0116207. DOI:10.1371/journal.pone.0116207; Falconer S, Laing, Robert. Reduced hospital stays for skin infections treated with dalbavancin. In: 28th European Congress on Clinical Microbiology and Infectious Diseases (ECCMID); 2018 Apr 21-24; Madrid.; Felder S. The variance of length of stay and the optimal DRG outlier payments. Int J Health Care Finance Econ. 2009 Sep;9(3):279-89. DOI:10.1007/s10754-008-9051-1; GKV-Spitzenverband; Verband der Privaten Krankenversicherung; Deutsche Krankenhausgesellschaft. Vereinbarung zum Fallpauschalensystem für Krankenhäuser für das Jahr 2018 (Fallpauschalenvereinbarung 2018 - FPV 2018). 2018. Available from: https://www.gkv-spitzenverband.de/media/dokumente/krankenversicherung_1/krankenhaeuser/drg/drg_2018/FPV_2018.pdf; Hernández A, Yagüe G, García Vázquez E, Simón M, Moreno Parrado L, Canteras M, Gómez J. Infecciones nosocomiales por Pseudomonas aeruginosa multiresistente incluido carbapenémicos: factores predictivos y pronósticos. Estudio prospectivo 2016-2017 [Nosocomial infections caused by multiresistant Pseudomonas aeruginosa (carbapenems included): predictive and prognostic factors. A prospective study (2016-2017)]. Rev Esp Quimioter. 2018 Apr;31(2):123-30.; Hübner C, Hübner NO, Hopert K, Maletzki S, Flessa S. Analysis of MRSA-attributed costs of hospitalized patients in Germany. Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1817-22. DOI:10.1007/s10096-014-2131-x; InEK GmbH. Fallpauschalenkatalog 2018. Available from: https://www.g-drg.de/content/download/7387/55403/version/1/file/Fallpauschalen_Katalog_2018_171124.pdf; Inmed. Über uns. Available from: https://www.simplexitaet.de/de/ueber-uns2.html; Itani KM, Dryden MS, Bhattacharyya H, Kunkel MJ, Baruch AM, Weigelt JA. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. Am J Surg. 2010 Jun;199(6):804-16. DOI:10.1016/j.amjsurg.2009.08.045; Jenkins TC, Sabel AL, Sarcone EE, Price CS, Mehler PS, Burman WJ. Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship. Clin Infect Dis. 2010 Oct;51(8):895-903. DOI:10.1086/656431; Jerosch J, Linke C, editors. Patientenzentrierte Medizin in Orthopädie und Unfallchirurgie: Lösungen für Patientenorientierung, Qualität und Wirtschaftlichkeit. Berlin, Heidelberg: Springer; 2016. DOI:10.1007/978-3-662-48081-6; Juul JJ, Mullins CF, Peppard WJ, Huang AM. New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin. Ther Clin Risk Manag. 2016;12:225-32. DOI:10.2147/TCRM.S71855; Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother. 2002 Jun;49(6):897-903. DOI:10.1093/jac/dkf046; Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro Torné A, Witte W, Friedrich AW. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill. 2010 Oct;15(41):19688. DOI:10.2807/ese.15.41.19688-en; Laupland KB, Valiquette L. Outpatient parenteral antimicrobial therapy. Can J Infect Dis Med Microbiol. 2013;24(1):9-11. DOI:10.1155/2013/205910; Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis. 2005 May;9(3):127-38. DOI:10.1016/j.ijid.2004.09.009; Lener S, Hartmann S, Barbagallo GMV, Certo F, Thomé C, Tschugg A. Management of spinal infection: a review of the literature. Acta Neurochir (Wien). 2018 03;160(3):487-96. DOI:10.1007/s00701-018-3467-2; Li JZ, Willke RJ, Rittenhouse BE, Rybak MJ. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial. Surg Infect (Larchmt). 2003;4(1):57-70. DOI:10.1089/109629603764655290; Linke C. Verweildauer als Zielparameter der Patientenversorgung aus ökonomischer und medizinischer Sicht. In: Jerosch J, Linke C, editors. Patientenzentrierte Medizin in Orthopädie und Unfallchirurgie. Berlin, Heidelberg: Springer; 2016. DOI:10.1007/978-3-662-48081-6_11; Macedo-Viñas M, De Angelis G, Rohner P, Safran E, Stewardson A, Fankhauser C, Schrenzel J, Pittet D, Harbarth S. Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs. J Hosp Infect. 2013 Jun;84(2):132-7. DOI:10.1016/j.jhin.2013.02.015; Martí-Carvajal AJ, Dayer M, Conterno LO, Gonzalez Garay AG, Martí-Amarista CE, Simancas-Racines D. A comparison of different antibiotic regimens for the treatment of infective endocarditis. Cochrane Database Syst Rev. 2016 Apr;4:CD009880. DOI:10.1002/14651858.CD009880.pub2; Nair T, Fitzgerald J, Ly B, Wallace MR. Dalbavancin as a cost effective antibiotic. Infect Dis (Lond). 2018 01;50(1):75-6. DOI:10.1080/23744235.2017.1365169; Nathwani D, Dryden M, Garau J. Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe. Int J Antimicrob Agents. 2016 Aug;48(2):127-36. DOI:10.1016/j.ijantimicag.2016.04.023; Nguyen-Van-Tam SE, Nguyen-Van-Tam JS, Myint S, Pearson JC. Risk factors for hospital-acquired urinary tract infection in a large English teaching hospital: a case-control study. Infection. 1999 May-Jun;27(3):192-7. DOI:10.1007/bf02561527; Office of Communications / Division of Drug Information. Guidance for Industry: Acute Bacterial Skin and Skin Structure Infections: Developing Drugs for Treatment. 2013. Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm; Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis. 2010 Sep;51 Suppl 2:S198-208. DOI:10.1086/653520; Rao N, Ziran BH, Lipsky BA. Treating osteomyelitis: antibiotics and surgery. Plast Reconstr Surg. 2011 Jan;127 Suppl 1:177S-87S. DOI:10.1097/PRS.0b013e3182001f0f; Resch A, Wilke M, Fink C. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals. Eur J Health Econ. 2009 Jul;10(3):287-97. DOI:10.1007/s10198-008-0132-3; Righi E, Carnelutti A, Vena A, Bassetti M. Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin. Infect Drug Resist. 2018;11:479-88. DOI:10.2147/IDR.S142140; Robert Koch-Institut (RKI). Eigenschaften, Häufigkeit und Verbreitung von MRSA in Deutschland. Krankenhhyg Infektionsverhütung. 2018;40(2):73-7. DOI:10.1016/j.khinf.2018.03.001; Roeder N, Hensen P, Franz D, editors. Gesundheitsökonomie, Gesundheitssystem und öffentliche Gesundheitspflege: Ein praxisorientiertes Kurzlehrbuch. 2 ed. Köln: Dt. Ärzte-Verl.; 2014.; Sharpe JN, Shively EH, Polk HC Jr. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. Am J Surg. 2005 Apr;189(4):425-8. DOI:10.1016/j.amjsurg.2005.01.011; Statistisches Bundesamt (Destatis). Gesundheit: Fallpauschalenbezogene Krankenhausstatistik (DRG-Statistik). Diagnosen, Prozeduren, Fallpauschalen und Case Mix der vollstationären Patientinnen und Patienten in Krankenhäusern. Wiesbaden; 2017 [updated 2018 Mar 03]. (Fachserie 12/Reihe 6.4). Available from: https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Gesundheit/Krankenhaeuser/Publikationen/Downloads-Krankenhaeuser/fallpauschalen-krankenhaus-2120640167004.pdf?__blob=publicationFile; Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, Gainer RB, Kunkel MJ, Yancey RW, Williams DN; IDSA. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis. 2004 Jun;38(12):1651-72. DOI:10.1086/420939; Tobudic S, Forstner C, Burgmann H, Lagler H, Ramharter M, Steininger C, Vossen MG, Winkler S, Thalhammer F. Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna. Clin Infect Dis. 2018 Aug;67(5):795-8. DOI:10.1093/cid/ciy279; Walsh TL, Chan L, Konopka CI, Burkitt MJ, Moffa MA, Bremmer DN, Murillo MA, Watson C, Chan-Tompkins NH. Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients. BMC Infect Dis. 2016 Nov;16(1):721. DOI:10.1186/s12879-016-2067-0; http://dx.doi.org/10.3205/id000043; http://nbn-resolving.de/urn:nbn:de:0183-id0000434; http://www.egms.de/en/journals/id/2019-7/id000043.shtml
-
7Conference
المؤلفون: Rathmayer, M, Schmidt, A, Schepp, W, Heinlein, W, Albert, JG, Gundling, F
المصدر: Zeitschrift für Gastroenterologie ; 74. Jahrestagung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten mit Sektion Endoskopie – 13. Herbsttagung der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie gemeinsam mit den Arbeitsgemeinschaften der DGAV ; ISSN 1439-7803
-
8Academic Journal
المؤلفون: Anemüller, J, Rathmayer, M, Heinlein, W, Rohrbach, H, Lerch, M, Schepp, W, Gundling, F
المصدر: Zeitschrift für Gastroenterologie ; volume 56, issue 08, page e358-e358 ; ISSN 0044-2771 1439-7803
-
9Academic Journal
Alternate Title: Early optimization of antibiotic therapy through rapid detection of pathogens and sensitivity: Health economic aspects. (English)
المؤلفون: Wilke, M., Worf, K., Heinlein, W., Kast, T., Bodmann, K.-F.
المصدر: Medizinische Klinik: Intensivmedizin & Notfallmedizin; Jun2020, Vol. 115 Issue 5, p420-427, 8p
-
10Academic Journal
المؤلفون: Bodmann, K. F., Schenker, M., Heinlein, W., Wilke, M. H.
المصدر: Medizinische Klinik - Intensivmedizin und Notfallmedizin ; volume 113, issue 7, page 533-541 ; ISSN 2193-6218 2193-6226
-
11Academic Journal
المؤلفون: Rathmayer, M., Scheffer, H., Braun, M., Heinlein, W., Akoglu, B., Brechmann, T., Gölder, S., Lankisch, T., Messmann, Helmut, Schneider, A., Wagner, M., Fleßa, S., Meier, A., Lewerenz, B., Gossner, L., Faiss, S., Toermer, T., Werner, T., Wilke, M., Lerch, M., Schepp, W.
Relation: https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/89935; https://doi.org/10.1055/s-0034-1399199
-
12Academic Journal
المؤلفون: Grube, R., Heinlein, W., Scheffer, H., Rathmayer, M., Schepp, W., Lohse, A., Stallmach, A., Wilke, M., Lerch, M.
المصدر: Zeitschrift für Gastroenterologie ; volume 53, issue 05, page 391-397 ; ISSN 0044-2771 1439-7803
-
13Academic Journal
Alternate Title: Procalcitonin as a tool for the assessment of successful therapy of severe sepsis. (English)
المؤلفون: Bodmann, K. F., Schenker, M., Heinlein, W., Wilke, M. H.
المصدر: Medizinische Klinik: Intensivmedizin & Notfallmedizin; Oct2018, Vol. 113 Issue 7, p533-541, 9p
-
14Conference
المؤلفون: Marques, M.B., Andreasen, S.B., Fellegara, A., Artiglia, M., Meier, Jens, Heinlein, W., Emplit, Philippe, Wittl, F., Vobian, J., Dultz, W., Wabnitz, Stefan
المصدر: In: Proceedings of the 4th Optical fibre measurement conference. National Physical Laboratory, Teddington
مصطلحات موضوعية: Sciences de l'ingénieur, Optique
وصف الملف: No full-text files
-
15Academic Journal
المؤلفون: Hummel, M., Heinlein, W., Banholzer, P., Standl, E., Ziegler, A.G.
المصدر: Der Internist ; volume 42, issue 2, page 279-283 ; ISSN 0020-9554 1432-1289
-
16Book
المؤلفون: Schalhorn, A., Peyerl, G., Heinlein, W., Wilmanns, W.
المصدر: Progress in Regional Cancer Therapy ; page 70-74 ; ISBN 9783642748202 9783642748189
-
17Academic Journal
المؤلفون: Röss, D., Gehrer, G., Heinlein, W.
المصدر: Zeitschrift für Naturforschung A ; volume 20, issue 2, page 256-263 ; ISSN 1865-7109 0932-0784
-
18Academic Journal
المؤلفون: Linn, J, Ferring, P, Heinlein, W
المصدر: Pure and Applied Optics: Journal of the European Optical Society Part A ; volume 4, issue 4, page 349-357 ; ISSN 0963-9659 1361-6617
-
19Academic Journal
المؤلفون: Possinger, K.W., Claasen, S., Beykirch, M.K., Heinlein, W., Wilmanns, W.
المصدر: Therapiewoche 5, 205-214 (1992)
Relation: info:eu-repo/semantics/altIdentifier/wos/undefined; info:eu-repo/semantics/altIdentifier/isbn/0935-3208; info:eu-repo/semantics/altIdentifier/pissn/0040-5973; https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=40492; urn:isbn:0935-3208; urn:issn:0040-5973
-
20Academic Journal
المؤلفون: Lieber, W., Loch, M., Etzkorn, H., Heinlein, W., Klein, K., Bonewitz, H., Muhlich, A.
المصدر: Journal of Lightwave Technology; 1986, Vol. 4 Issue 7, p715-719, 5p